Search / Trial NCT06232499

Effects of Intravenous Laser Irradiation of Blood Treatment With Different Colored Lights on Controlling Recurrent Stroke Risk Factors and Neurological Function in Stroke Patients

Launched by TAIPEI HOSPITAL, MINISTRY OF HEALTH AND WELFARE · Jan 22, 2024

Trial Information

Current as of December 21, 2024

Active, not recruiting

Keywords

Stroke Intravenous Laser Irradiation Of Blood Recurrent Stroke Risk Factors

ClinConnect Summary

This clinical trial is exploring how different colored lights used in a special treatment called intravenous laser irradiation can help stroke patients. The main goal is to see if these colored lights can improve brain function and help manage the risk factors for having another stroke. Participants in the study will be individuals aged 20 and older who have experienced their first stroke within the last six months. To join, they need to be healthy enough to undergo the treatments and not have certain medical conditions, like skin diseases or heart pacemakers.

In this trial, eligible participants will receive 10 sessions of treatment using infrared light and 10 sessions using blue light. Before each treatment, they will have blood tests and neurological evaluations to check their health and progress. The study aims to find out if one type of light is more effective than the other in helping with recovery after a stroke. If you or a loved one fits the criteria, participating could provide valuable insights into new treatments for stroke recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Diagnosed as a first-time stroke patient.
  • 2. Onset of illness within 6 months of enrollment.
  • 3. Recruitment period from January to December of the year 113.
  • 4. All participants or their legal representatives must sign the informed consent form.
  • Exclusion Criteria:
  • 1. Skin diseases that make injection or photosensitivity unsuitable.
  • 2. Pregnancy and abnormal blood clotting function.
  • 3. Presence of a cardiac pacemaker.
  • 4. Inability to comply with the 5-month study plan.

About Taipei Hospital, Ministry Of Health And Welfare

Taipei Hospital, under the Ministry of Health and Welfare of Taiwan, is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. With a commitment to enhancing patient outcomes and public health, the hospital integrates state-of-the-art facilities and a multidisciplinary team of experts to conduct rigorous clinical studies across various therapeutic areas. As a sponsor, Taipei Hospital prioritizes ethical standards, patient safety, and scientific integrity, contributing valuable insights to the global medical community and fostering collaboration to address pressing health challenges.

Locations

New Taipei City, Roc, Taiwan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0